Need help finding what you are looking for?
Contact Us
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1424998
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1424998
Pancreatic Cancer Therapeutics & Diagnostics Market, By Treatment Type, Diagnostic, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
PUBLISHED:
PAGES: 290 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
REPORT HIGHLIGHT
Pancreatic Cancer Therapeutics & Diagnostics Market size was valued at USD 2,470.6 Million in 2022, expanding at a CAGR of 5.5% from 2023 to 2030.
Pancreatic cancer therapeutics and diagnostics encompass medical procedures for both the diagnosis and subsequent treatment of pancreatic cancer. Globally, pancreatic cancer stands as a significant contributor to cancer-related fatalities, with the disease burden escalating rapidly. According to the American Cancer Society, the 5-year relative survival rates are approximately 44% for localized cases, 15% for regional cases, and 3% for distant cases. In response, healthcare professionals and authorities are underscoring the need to develop and commercialize precise screening methods to monitor prevalence levels.
Pancreatic Cancer Therapeutics & Diagnostics Market- Market Dynamics
Rising incidence of pancreatic cancer, advancements in molecular biology, drug development, and diagnostic technology is expected to propel the market demand
The market growth is driven by factors such as the rising incidence of pancreatic cancer, advancements in molecular biology, drug development, and diagnostic technology. The market is poised for significant expansion due to increased research and development initiatives, favorable reimbursement scenarios, and the introduction of innovative products. Notably, in January 2019, scientists at the Van Andel Research Institute introduced a novel blood test (CA19-9 test) that, when combined with an existing test, can detect nearly 70% of pancreatic cancers with a false-positive rate of less than 5%. Additionally, Myriad Genetics Inc. announced in January 2021 that its BRACAnalysis Diagnostic System, used for pancreatic cancer screening, would receive reimbursement from Japan's Ministry of Health, Labour, and Welfare, potentially expanding the patient pool for genetic testing in Japan.Collaborations are also shaping the market positively. In October 2020, Oncolytics Biotech Inc. disclosed a collaboration with Roche and AIO for a phase 1/2 trial evaluating the efficacy of pelareorep and atezolizumab in treating metastatic pancreatic cancer. These developments are anticipated to have a favorable impact on market growth throughout the forecast period.
Pancreatic Cancer Therapeutics & Diagnostics Market- Key Insights
As per the analysis shared by our research analyst, the global Pancreatic Cancer Therapeutics & Diagnostics Market is estimated to grow annually at a CAGR of around 5.5% over the forecast period (2023-2030)
The Cancer Therapeutics & Diagnostics Market is projected to grow at a significant rate due to rising incidence of pancreatic cancer, advancements in molecular biology, drug development, and diagnostic technology
Based on end user, hospital was predicted to show maximum market share in the year 2022
Based on Treatment, chemotherapy segment was the leading type in 2022
On the basis of region, North America was the leading revenue generator in 2022
Pancreatic Cancer Therapeutics & Diagnostics Market- Segmentation Analysis:
The Global Pancreatic Cancer Therapeutics & Diagnostics Market is segmented on the basis of Treatment Type, Diagnostic, By End User, and Region.
The market is divided into three categories based on Treatment: Chemotherapy. Surgery, Other Treatments. Over the forecast period, it is anticipated that the chemotherapy segment will play a significant role in the studied market. Chemotherapy stands as a primary method of treating pancreatic cancer, functioning by impeding the growth and division of pancreatic cancer cells, effectively killing them. These chemotherapy drugs operate systemically, traveling through the bloodstream to target and damage cancer cells throughout the entire body.
The market is divided into four categories based on End User: Hospitals, Clinics, Laboratories, Others. In 2022, the pancreatic cancer diagnostics market was predominantly led by the hospitals segment in terms of revenue share. This prominence can be attributed to several factors, including heightened awareness of personalized medicines, enhancements in accessible healthcare services, an uptick in patient visits to hospitals, and an increasing emphasis on strategic initiatives, all of which are bolstering the growth of the hospital segment.
Pancreatic Cancer Therapeutics & Diagnostics Market- Geographical Insights
Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. North America is expected to dominate the market during the forecast period. The target illness's rising incidence and the rise in for-profit and nonprofit organizations' attempts to support early disease identification are driving the expansion of the North American area. One well-known group that supports research efforts and raises awareness of the disease is the Pancreatic Cancer Action Network.
Pancreatic Cancer Therapeutics & Diagnostics Market- Competitive Landscape:
In the pancreatic cancer therapeutic & diagnostic market, companies are actively pursuing strategies to capitalize on the increasing demand for Pancreatic Cancer Therapeutics & Diagnostics. In the field of pancreatic cancer therapeutics, pharmaceutical and biotechnology companies are involved in various activities, including new product launches, partnerships, collaborations, and research initiatives.
Recent Developments:
In January 2023, the evaluation of the radiotracer, 68Ga-Fibroblast-Activation-Protein-Inhibitors (FAPI)-46, in pancreatic cancer imaging through a clinical study was released by Mayo Clinic.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL PANCREATIC CANCER THERAPEUTICS & DIAGNOSTICS MARKET KEY PLAYERS
- Myriad Genetics Inc.
- Pfizer Inc.
- Novartis AG
- Bristol-Myers Squibb Company
- AstraZeneca PLC
- Amgen Inc.
- Viatris Inc.
- Boston Scientific Corporation
- FUJIFILM Holdings Corporation
- Canon Inc. (canon Medical Systems Corporation)
GLOBAL PANCREATIC CANCER THERAPEUTICS & DIAGNOSTICS MARKET, BY TREATMENT TYPE
- Targeted Therapies
- Chemotherapy
- Surgery
- Other Treatments
GLOBAL PANCREATIC CANCER THERAPEUTICS & DIAGNOSTICS MARKET, BY DIAGNOSTIC
- Imaging
- Biopsy
- Endoscopic Ultrasound
- Other Diagnostics
GLOBAL PANCREATIC CANCER THERAPEUTICS & DIAGNOSTICS MARKET, BY END USER
- Hospitals
- Clinics
- Laboratories
- Others
GLOBAL PANCREATIC CANCER THERAPEUTICS & DIAGNOSTICS MARKET, BY REGION
- North America
- The U.S.
- Canada
- Europe
- Germany
- France
- Italy
- Spain
- United Kingdom
- Russia
- Netherlands
- Sweden
- Poland
- Rest of Europe
- Asia Pacific
- India
- China
- South Korea
- Japan
- Australia
- Thailand
- Indonesia
- Philippines
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
- The Middle East and Africa
- Saudi Arabia
- United Arab Emirates
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
Product Code: ANV2198
Table of Contents
1. Pancreatic Cancer Therapeutics & Diagnostics Market Overview
- 1.1. Study Scope
- 1.2. Market Estimation Years
2. Executive Summary
- 2.1. Market Snippet
- 2.1.1. Pancreatic Cancer Therapeutics & Diagnostics Market Snippet by Treatment Type
- 2.1.2. Pancreatic Cancer Therapeutics & Diagnostics Market Snippet by Diagnostics
- 2.1.3. Pancreatic Cancer Therapeutics & Diagnostics Market Snippet by End Users
- 2.1.4. Pancreatic Cancer Therapeutics & Diagnostics Market Snippet by Country
- 2.1.5. Pancreatic Cancer Therapeutics & Diagnostics Market Snippet by Region
- 2.2. Competitive Insights
3. Pancreatic Cancer Therapeutics & Diagnostics Key Market Trends
- 3.1. Pancreatic Cancer Therapeutics & Diagnostics Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
- 3.2. Pancreatic Cancer Therapeutics & Diagnostics Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
- 3.3. Pancreatic Cancer Therapeutics & Diagnostics Market Opportunities
- 3.4. Pancreatic Cancer Therapeutics & Diagnostics Market Future Trends
4. Pancreatic Cancer Therapeutics & Diagnostics Industry Study
- 4.1. PEST Analysis
- 4.2. Porter's Five Forces Analysis
- 4.3. Growth Prospect Mapping
- 4.4. Regulatory Framework Analysis
5. Pancreatic Cancer Therapeutics & Diagnostics Market: COVID-19 Impact Analysis
- 5.1. Pre-COVID-19 Impact Analysis
- 5.2. Post-COVID-19 Impact Analysis
- 5.2.1. Top Performing Segments
- 5.2.2. Marginal Growth Segments
- 5.2.3. Top Looser Segments
- 5.2.4. Marginal Loss Segments
6. Pancreatic Cancer Therapeutics & Diagnostics Market Landscape
- 6.1. Pancreatic Cancer Therapeutics & Diagnostics Market Share Analysis, 2022
- 6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis
7. Pancreatic Cancer Therapeutics & Diagnostics Market - By Treatment Type
- 7.1. Overview
- 7.1.1. Segment Share Analysis, By Treatment Type, 2022 & 2030 (%)
- 7.1.2. Targeted Therapies
- 7.1.3. Chemotherapy
- 7.1.4. Surgery
- 7.1.5. Other Treatments
8. Pancreatic Cancer Therapeutics & Diagnostics Market - By Diagnostics
- 8.1. Overview
- 8.1.1. Segment Share Analysis, By Diagnostics, 2022 & 2030 (%)
- 8.1.2. Imaging
- 8.1.3. Biopsy
- 8.1.4. Endoscopic Ultrasound
- 8.1.5. Other Diagnostics
9. Pancreatic Cancer Therapeutics & Diagnostics Market - By End Users
- 9.1. Overview
- 9.1.1. Segment Share Analysis, By End Users, 2022 & 2030 (%)
- 9.1.2. Hospitals
- 9.1.3. Clinics
- 9.1.4. Laboratories
- 9.1.5. Others
10. Pancreatic Cancer Therapeutics & Diagnostics Market- By Geography
- 10.1. Introduction
- 10.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
- 10.2. North America
- 10.2.1. Overview
- 10.2.2. Pancreatic Cancer Therapeutics & Diagnostics Key Manufacturers in North America
- 10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 10.2.4. North America Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
- 10.2.5. North America Market Size and Forecast, By Diagnostics, 2018 - 2030 (US$ Million)
- 10.2.6. North America Market Size and Forecast, By End Users, 2018 - 2030 (US$ Million)
- 10.2.7. U.S.
- 10.2.7.1. Overview
- 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.2.7.3. U.S. Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
- 10.2.7.4. U.S. Market Size and Forecast, By Diagnostics, 2018 - 2030 (US$ Million)
- 10.2.7.5. U.S. Market Size and Forecast, By End Users, 2018 - 2030 (US$ Million)
- 10.2.8. Canada
- 10.2.8.1. Overview
- 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.2.8.3. Canada Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
- 10.2.8.4. Canada Market Size and Forecast, By Diagnostics, 2018 - 2030 (US$ Million)
- 10.2.8.5. Canada Market Size and Forecast, By End Users, 2018 - 2030 (US$ Million)
- 10.3. Europe
- 10.3.1. Overview
- 10.3.2. Pancreatic Cancer Therapeutics & Diagnostics Key Manufacturers in Europe
- 10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 10.3.4. Europe Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
- 10.3.5. Europe Market Size and Forecast, By Diagnostics, 2018 - 2030 (US$ Million)
- 10.3.6. Europe Market Size and Forecast, By End Users, 2018 - 2030 (US$ Million)
- 10.3.7. Germany
- 10.3.7.1. Overview
- 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.3.7.3. Germany Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
- 10.3.7.4. Germany Market Size and Forecast, By Diagnostics, 2018 - 2030 (US$ Million)
- 10.3.7.5. Germany Market Size and Forecast, By End Users, 2018 - 2030 (US$ Million)
- 10.3.8. Italy
- 10.3.8.1. Overview
- 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.3.8.3. Italy Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
- 10.3.8.4. Italy Market Size and Forecast, By Diagnostics, 2018 - 2030 (US$ Million)
- 10.3.8.5. Italy Market Size and Forecast, By End Users, 2018 - 2030 (US$ Million)
- 10.3.9. United Kingdom
- 10.3.9.1. Overview
- 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.3.9.3. United Kingdom Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
- 10.3.9.4. United Kingdom Market Size and Forecast, By Diagnostics, 2018 - 2030 (US$ Million)
- 10.3.9.5. United Kingdom Market Size and Forecast, By End Users, 2018 - 2030 (US$ Million)
- 10.3.10. France
- 10.3.10.1. Overview
- 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.3.10.3. France Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
- 10.3.10.4. France Market Size and Forecast, By Diagnostics, 2018 - 2030 (US$ Million)
- 10.3.10.5. France Market Size and Forecast, By End Users, 2018 - 2030 (US$ Million)
- 10.3.11. Russia
- 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.3.11.2. Russia Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
- 10.3.11.3. Russia Market Size and Forecast, By Diagnostics, 2018 - 2030 (US$ Million)
- 10.3.11.4. Russia Market Size and Forecast, By End Users, 2018 - 2030 (US$ Million)
- 10.3.12. Netherlands
- 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.3.12.2. Netherlands Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
- 10.3.12.3. Netherlands Market Size and Forecast, By Diagnostics, 2018 - 2030 (US$ Million)
- 10.3.12.4. Netherlands Market Size and Forecast, By End Users, 2018 - 2030 (US$ Million)
- 10.3.13. Sweden
- 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.3.13.2. Sweden Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
- 10.3.13.3. Sweden Market Size and Forecast, By Diagnostics, 2018 - 2030 (US$ Million)
- 10.3.13.4. Sweden Market Size and Forecast, By End Users, 2018 - 2030 (US$ Million)
- 10.3.14. Poland
- 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.3.14.2. Poland Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
- 10.3.14.3. Poland Market Size and Forecast, By Diagnostics, 2018 - 2030 (US$ Million)
- 10.3.14.4. Poland Market Size and Forecast, By End Users, 2018 - 2030 (US$ Million)
- 10.3.15. Rest of Europe
- 10.3.15.1. Overview
- 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.3.15.3. Rest of the Europe Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
- 10.3.15.4. Rest of the Europe Market Size and Forecast, By Diagnostics, 2018 - 2030 (US$ Million)
- 10.3.15.5. Rest of the Europe Market Size and Forecast, By End Users, 2018 - 2030 (US$ Million)
- 10.4. Asia Pacific (APAC)
- 10.4.1. Overview
- 10.4.2. Pancreatic Cancer Therapeutics & Diagnostics Key Manufacturers in Asia Pacific
- 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 10.4.4. Asia Pacific Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
- 10.4.5. Asia Pacific Market Size and Forecast, By Diagnostics, 2018 - 2030 (US$ Million)
- 10.4.6. Asia Pacific Market Size and Forecast, By End Users, 2018 - 2030 (US$ Million)
- 10.4.7. India
- 10.4.7.1. Overview
- 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.4.7.3. India Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
- 10.4.7.4. India Market Size and Forecast, By Diagnostics, 2018 - 2030 (US$ Million)
- 10.4.7.5. India Market Size and Forecast, By End Users, 2018 - 2030 (US$ Million)
- 10.4.8. China
- 10.4.8.1. Overview
- 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.4.8.3. China Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
- 10.4.8.4. China Market Size and Forecast, By Diagnostics, 2018 - 2030 (US$ Million)
- 10.4.8.5. China Market Size and Forecast, By End Users, 2018 - 2030 (US$ Million)
- 10.4.9. Japan
- 10.4.9.1. Overview
- 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.4.9.3. Japan Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
- 10.4.9.4. Japan Market Size and Forecast, By Diagnostics, 2018 - 2030 (US$ Million)
- 10.4.9.5. Japan Market Size and Forecast, By End Users, 2018 - 2030 (US$ Million)
- 10.4.10. South Korea
- 10.4.10.1. Overview
- 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.4.10.3. South Korea Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
- 10.4.10.4. South Korea Market Size and Forecast, By Diagnostics, 2018 - 2030 (US$ Million)
- 10.4.10.5. South Korea Market Size and Forecast, By End Users, 2018 - 2030 (US$ Million)
- 10.4.11. Australia
- 10.4.11.1. Overview
- 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.4.11.3. Australia Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
- 10.4.11.4. Australia Market Size and Forecast, By Diagnostics, 2018 - 2030 (US$ Million)
- 10.4.11.5. Australia Market Size and Forecast, By End Users, 2018 - 2030 (US$ Million)
- 10.4.12. Thailand
- 10.4.12.1. Overview
- 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.4.12.3. Thailand Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
- 10.4.12.4. Thailand Market Size and Forecast, By Diagnostics, 2018 - 2030 (US$ Million)
- 10.4.12.5. Thailand Market Size and Forecast, By End Users, 2018 - 2030 (US$ Million)
- 10.4.13. Indonesia
- 10.4.13.1. Overview
- 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.4.13.3. Indonesia Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
- 10.4.13.4. Indonesia Market Size and Forecast, By Diagnostics, 2018 - 2030 (US$ Million)
- 10.4.13.5. Indonesia Market Size and Forecast, By End Users, 2018 - 2030 (US$ Million)
- 10.4.14. Philippines
- 10.4.14.1. Overview
- 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.4.14.3. Philippines Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
- 10.4.14.4. Philippines Market Size and Forecast, By Diagnostics, 2018 - 2030 (US$ Million)
- 10.4.14.5. Philippines Market Size and Forecast, By End Users, 2018 - 2030 (US$ Million)
- 10.4.15. Rest of APAC
- 10.4.15.1. Overview
- 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.4.15.3. Rest of APAC Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
- 10.4.15.4. Rest of APAC Market Size and Forecast, By Diagnostics, 2018 - 2030 (US$ Million)
- 10.4.15.5. Rest of APAC Market Size and Forecast, By End Users, 2018 - 2030 (US$ Million)
- 10.5. Latin America
- 10.5.1. Overview
- 10.5.2. Pancreatic Cancer Therapeutics & Diagnostics Key Manufacturers in Latin America
- 10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 10.5.4. Latin America Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
- 10.5.5. Latin America Market Size and Forecast, By Diagnostics, 2018 - 2030 (US$ Million)
- 10.5.6. Latin America Market Size and Forecast, By End Users, 2018 - 2030 (US$ Million)
- 10.5.7. Brazil
- 10.5.7.1. Overview
- 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.5.7.3. Brazil Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
- 10.5.7.4. Brazil Market Size and Forecast, By Diagnostics, 2018 - 2030 (US$ Million)
- 10.5.7.5. Brazil Market Size and Forecast, By End Users, 2018 - 2030 (US$ Million)
- 10.5.8. Mexico
- 10.5.8.1. Overview
- 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.5.8.3. Mexico Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
- 10.5.8.4. Mexico Market Size and Forecast, By Diagnostics, 2018 - 2030 (US$ Million)
- 10.5.8.5. Mexico Market Size and Forecast, By End Users, 2018 - 2030 (US$ Million)
- 10.5.9. Argentina
- 10.5.9.1. Overview
- 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.5.9.3. Argentina Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
- 10.5.9.4. Argentina Market Size and Forecast, By Diagnostics, 2018 - 2030 (US$ Million)
- 10.5.9.5. Argentina Market Size and Forecast, By End Users, 2018 - 2030 (US$ Million)
- 10.5.10. Colombia
- 10.5.10.1. Overview
- 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.5.10.3. Colombia Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
- 10.5.10.4. Colombia Market Size and Forecast, By Diagnostics, 2018 - 2030 (US$ Million)
- 10.5.10.5. Colombia Market Size and Forecast, By End Users, 2018 - 2030 (US$ Million)
- 10.5.11. Rest of LATAM
- 10.5.11.1. Overview
- 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.5.11.3. Rest of LATAM Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
- 10.5.11.4. Rest of LATAM Market Size and Forecast, By Diagnostics, 2018 - 2030 (US$ Million)
- 10.5.11.5. Rest of LATAM Market Size and Forecast, By End Users, 2018 - 2030 (US$ Million)
- 10.6. Middle East and Africa
- 10.6.1. Overview
- 10.6.2. Pancreatic Cancer Therapeutics & Diagnostics Key Manufacturers in Middle East and Africa
- 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 10.6.4. Middle East and Africa Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
- 10.6.5. Middle East and Africa Market Size and Forecast, By Diagnostics, 2018 - 2030 (US$ Million)
- 10.6.6. Middle East and Africa Market Size and Forecast, By End Users, 2018 - 2030 (US$ Million)
- 10.6.7. Saudi Arabia
- 10.6.7.1. Overview
- 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.6.7.3. Saudi Arabia Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
- 10.6.7.4. Saudi Arabia Market Size and Forecast, By Diagnostics, 2018 - 2030 (US$ Million)
- 10.6.7.5. Saudi Arabia Market Size and Forecast, By End Users, 2018 - 2030 (US$ Million)
- 10.6.8. United Arab Emirates
- 10.6.8.1. Overview
- 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.6.8.3. United Arab Emirates Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
- 10.6.8.4. United Arab Emirates Market Size and Forecast, By Diagnostics, 2018 - 2030 (US$ Million)
- 10.6.8.5. United Arab Emirates Market Size and Forecast, By End Users, 2018 - 2030 (US$ Million)
- 10.6.9. Israel
- 10.6.9.1. Overview
- 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.6.9.3. Israel Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
- 10.6.9.4. Israel Market Size and Forecast, By Diagnostics, 2018 - 2030 (US$ Million)
- 10.6.9.5. Israel Market Size and Forecast, By End Users, 2018 - 2030 (US$ Million)
- 10.6.10. Turkey
- 10.6.10.1. Overview
- 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.6.10.3. Turkey Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
- 10.6.10.4. Turkey Market Size and Forecast, By Diagnostics, 2018 - 2030 (US$ Million)
- 10.6.10.5. Turkey Market Size and Forecast, By End Users, 2018 - 2030 (US$ Million)
- 10.6.11. Algeria
- 10.6.11.1. Overview
- 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.6.11.3. Algeria Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
- 10.6.11.4. Algeria Market Size and Forecast, By Diagnostics, 2018 - 2030 (US$ Million)
- 10.6.11.5. Algeria Market Size and Forecast, By End Users, 2018 - 2030 (US$ Million)
- 10.6.12. Egypt
- 10.6.12.1. Overview
- 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.6.12.3. Egypt Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
- 10.6.12.4. Egypt Market Size and Forecast, By Diagnostics, 2018 - 2030 (US$ Million)
- 10.6.12.5. Egypt Market Size and Forecast, By End Users, 2018 - 2030 (US$ Million)
- 10.6.13. Rest of MEA
- 10.6.13.1. Overview
- 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.6.13.3. Rest of MEA Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
- 10.6.13.4. Rest of MEA Market Size and Forecast, By Diagnostics, 2018 - 2030 (US$ Million)
- 10.6.13.5. Rest of MEA Market Size and Forecast, By End Users, 2018 - 2030 (US$ Million)
11. Key Vendor Analysis- Pancreatic Cancer Therapeutics & Diagnostics Industry
- 11.1. Competitive Dashboard
- 11.2. Company Profiles
- 11.2.1. Myriad Genetics Inc.
- 11.2.2. Pfizer Inc.
- 11.2.3. Novartis AG
- 11.2.4. Bristol-Myers Squibb Company
- 11.2.5. AstraZeneca PLC
- 11.2.6. Amgen Inc.
- 11.2.7. Viatris Inc.
- 11.2.8. Boston Scientific Corporation
- 11.2.9. FUJIFILM Holdings Corporation
- 11.2.10. Canon Inc. (canon Medical Systems Corporation)
12. 360 Degree Analyst View
13. Appendix
- 13.1. Research Methodology
- 13.2. References
- 13.3. Abbreviations
- 13.4. Disclaimer
- 13.5. Contact Us
Product Code: ANV2198
List of Tables
- TABLE List of data sources
- TABLE Market drivers; Impact Analysis
- TABLE Market restraints; Impact Analysis
- TABLE Pancreatic Cancer Therapeutics & Diagnostics Market: Treatment Type Snapshot (2022)
- TABLE Segment Dashboard; Definition and Scope, by Treatment Type
- TABLE Global Pancreatic Cancer Therapeutics & Diagnostics Market, by Treatment Type 2018-2030 (USD Million)
- TABLE Pancreatic Cancer Therapeutics & Diagnostics Market: Diagnostics Snapshot (2022)
- TABLE Segment Dashboard; Definition and Scope, by Diagnostics
- TABLE Global Pancreatic Cancer Therapeutics & Diagnostics Market, by Diagnostics 2018-2030 (USD Million)
- TABLE Pancreatic Cancer Therapeutics & Diagnostics Market: End Users Snapshot (2022)
- TABLE Segment Dashboard; Definition and Scope, by End Users
- TABLE Global Pancreatic Cancer Therapeutics & Diagnostics Market, by End Users 2018-2030 (USD Million)
- TABLE Pancreatic Cancer Therapeutics & Diagnostics Market: Regional snapshot (2022)
- TABLE Segment Dashboard; Definition and Scope, by Region
- TABLE Global Pancreatic Cancer Therapeutics & Diagnostics Market, by Region 2018-2030 (USD Million)
- TABLE North America Pancreatic Cancer Therapeutics & Diagnostics Market, by Country, 2018-2030 (USD Million)
- TABLE North America Pancreatic Cancer Therapeutics & Diagnostics Market, by Treatment Type, 2018-2030 (USD Million)
- TABLE North America Pancreatic Cancer Therapeutics & Diagnostics Market, by Diagnostics, 2018-2030 (USD Million)
- TABLE North America Pancreatic Cancer Therapeutics & Diagnostics Market, by End Users, 2018-2030 (USD Million)
- TABLE Europe Pancreatic Cancer Therapeutics & Diagnostics Market, by Country, 2018-2030 (USD Million)
- TABLE Europe Pancreatic Cancer Therapeutics & Diagnostics Market, by Treatment Type, 2018-2030 (USD Million)
- TABLE Europe Pancreatic Cancer Therapeutics & Diagnostics Market, by Diagnostics, 2018-2030 (USD Million)
- TABLE Europe Pancreatic Cancer Therapeutics & Diagnostics Market, by End Users, 2018-2030 (USD Million)
- TABLE Asia Pacific Pancreatic Cancer Therapeutics & Diagnostics Market, by Country, 2018-2030 (USD Million)
- TABLE Asia Pacific Pancreatic Cancer Therapeutics & Diagnostics Market, by Treatment Type, 2018-2030 (USD Million)
- TABLE Asia Pacific Pancreatic Cancer Therapeutics & Diagnostics Market, by Diagnostics, 2018-2030 (USD Million)
- TABLE Asia Pacific Pancreatic Cancer Therapeutics & Diagnostics Market, by End Users, 2018-2030 (USD Million)
- TABLE Latin America Pancreatic Cancer Therapeutics & Diagnostics Market, by Country, 2018-2030 (USD Million)
- TABLE Latin America Pancreatic Cancer Therapeutics & Diagnostics Market, by Treatment Type, 2018-2030 (USD Million)
- TABLE Latin America Pancreatic Cancer Therapeutics & Diagnostics Market, by Diagnostics, 2018-2030 (USD Million)
- TABLE Latin America Pancreatic Cancer Therapeutics & Diagnostics Market, by End Users, 2018-2030 (USD Million)
- TABLE Middle East and Africa Pancreatic Cancer Therapeutics & Diagnostics Market, by Country, 2018-2030 (USD Million)
- TABLE Middle East and Africa Pancreatic Cancer Therapeutics & Diagnostics Market, by Treatment Type, 2018-2030 (USD Million)
- TABLE Middle East and Africa Pancreatic Cancer Therapeutics & Diagnostics Market, by Diagnostics, 2018-2030 (USD Million)
- TABLE Middle East and Africa Pancreatic Cancer Therapeutics & Diagnostics Market, by End Users, 2018-2030 (USD Million)
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.